Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul D Santos

Showing results (1-10 of 492) with videos related to

Pageof 50
Sort By:
JACC. Basic to Translational Science|December 6, 2021
Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning ModelsRaul D Santos
JAMA Network Open|February 11, 2022
Calcified and Noncalcified Coronary Plaques and Atherosclerotic Cardiovascular Events in Patients With Severe Hypercholesterolemia-Moving Forward With Risk Stratification and TherapyRaul D Santos
The Lancet. Diabetes & Endocrinology|July 24, 2023
Lipoprotein(a) and subclinical vascular disease progression in children with familial hypercholesterolaemiaRaul D Santos
Atherosclerosis|July 13, 2010
Coronary artery calcification progression and cardiovascular events in renal transplant recipients, bad inheritance from previous kidney disease: commentary on the study of Roe et alRaul D Santos
Annals of Internal Medicine|November 17, 2010
ACP Journal Club. Review: Fibrates reduce risk for cardiovascular outcomesRaul D Santos
Cardiology|September 25, 2009
Uric acid and cardiovascular disease: how to solve another chicken or egg puzzleRaul D Santos
The Lancet. Diabetes & Endocrinology|December 21, 2025
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?Raul D Santos
Journal of the American College of Cardiology|March 18, 2014
Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor?Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|February 23, 2018
Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the DotsRaul D Santos
European Journal of Preventive Cardiology|October 4, 2017
Better health literacy can make the difference when control of risk factors for cardiovascular disease and quality of life are concernedRaul D Santos
Pageof 50

Showing results (1-10 of 492) with videos related to

Sort By:
Pageof 50
JACC. Basic to Translational Science|December 6, 2021
Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning ModelsRaul D Santos
JAMA Network Open|February 11, 2022
Calcified and Noncalcified Coronary Plaques and Atherosclerotic Cardiovascular Events in Patients With Severe Hypercholesterolemia-Moving Forward With Risk Stratification and TherapyRaul D Santos
The Lancet. Diabetes & Endocrinology|July 24, 2023
Lipoprotein(a) and subclinical vascular disease progression in children with familial hypercholesterolaemiaRaul D Santos
Atherosclerosis|July 13, 2010
Coronary artery calcification progression and cardiovascular events in renal transplant recipients, bad inheritance from previous kidney disease: commentary on the study of Roe et alRaul D Santos
Annals of Internal Medicine|November 17, 2010
ACP Journal Club. Review: Fibrates reduce risk for cardiovascular outcomesRaul D Santos
Cardiology|September 25, 2009
Uric acid and cardiovascular disease: how to solve another chicken or egg puzzleRaul D Santos
The Lancet. Diabetes & Endocrinology|December 21, 2025
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?Raul D Santos
Journal of the American College of Cardiology|March 18, 2014
Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor?Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|February 23, 2018
Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the DotsRaul D Santos
European Journal of Preventive Cardiology|October 4, 2017
Better health literacy can make the difference when control of risk factors for cardiovascular disease and quality of life are concernedRaul D Santos
Pageof 50